Association of tobacco use and cessation with coronary atherosclerosis

Atherosclerosis

Volumn 257, Issue , 2017, Pages 201-207

  Cheezum, Michael K ^a   Kim, Alexander ^b   Bittencourt, Marcio S ^c,d   Kassop, David ^e   Nissen, Alexander ^b   Thomas, Dustin M ^f   Nguyen, Binh ^a   Glynn, Robert J ^g   Shah, Nishant R ^h   Villines, Todd C ^a  

^a WALTER REED ARMY MEDICAL CENTER   (United States)

^b UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

^d HOSPITAL ISRAELITA ALBERT EINSTEIN   (Brazil)

^e WOMACK ARMY MEDICAL CENTER   (United States)

^f SAN ANTONIO MILITARY MEDICAL CENTER   (United States)

^g HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^h BROWN UNIVERSITY   (United States)

Author keywords

Atherosclerosis; Coronary artery disease; Coronary computed tomographic angiography; Smoking; Tobacco

Indexed keywords

ADULT; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY CALCIUM SCORE; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SMOKING; SMOKING CESSATION; TOBACCO USE; ATHEROSCLEROTIC PLAQUE; CHI SQUARE DISTRIBUTION; COMPARATIVE STUDY; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CORONARY BLOOD VESSEL; CORONARY STENOSIS; CROSS-SECTIONAL STUDY; DIAGNOSTIC IMAGING; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PREVENTION AND CONTROL; PROCEDURES; RISK FACTOR; SEVERITY OF ILLNESS INDEX; STATISTICAL MODEL; TIME FACTOR; VASCULAR CALCIFICATION;

ADULT; CHI-SQUARE DISTRIBUTION; COMPUTED TOMOGRAPHY ANGIOGRAPHY; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CORONARY STENOSIS; CORONARY VESSELS; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PLAQUE, ATHEROSCLEROTIC; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SMOKING; SMOKING CESSATION; TIME FACTORS; VASCULAR CALCIFICATION;

EID: 85008195296     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2016.11.016     Document Type: Article

References (30)

1. [1] Ford, E.S., Ajani, U.A., Croft, J.B., Critchley, J.A., Labarthe, D.R., Kottke, T.E., et al. Explaining the decrease in U.S. deaths from coronary disease, 1980-2000. N. Engl. J. Med. 356:23 (2007), 2388–2398.
2. [2] Centers for Disease Control and Prevention, Current cigarette smoking among Adults—United States, 2005–2013. Morb. Mortal. Wkly. Rep. 63:47 (2014), 1108–1112 (accessed 30.06.15).
3. [3] U.S. Department of Health and Human Services, The Health Consequences of Smoking—50 Years of Progress: a Report of the Surgeon General., 2014, U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, Atlanta (accessed 30.06.15).
4. [4] Hulten, E.A., Carbonaro, S., Petrillo, S.P., Mitchell, J.D., Villines, T.C., Prognostic value of cardiac computed tomography angiography: a systematic review and meta-analysis. J. Am. Coll. Cardiol. 57:10 (2011), 1237–1247.
5. [5] Nakanishi, R., Berman, D.S., Budoff, M.J., Gransar, H., Achenbach, S., Al-Mallah, M., et al. Current but not past smoking increases the risk of cardiac events: insights from coronary computed tomographic angiography. Eur. Heart J. 36:17 (2015), 1031–1040.
6. [6] Kim, J.A., Chun, E.J., Lee, M.S., Kim, K.J., Choi, S.I., Relationship between amount of cigarette smoking and coronary atherosclerosis on coronary CTA in asymptomatic individuals. Int. J. Cardiovasc. imaging 29:Suppl 1 (2013), 21–28.
7. [7] Cheezum, M.K., Hulten, E.A., Smith, R.M., Taylor, A.J., Kircher, J., Surry, L., et al. Changes in preventive medical therapies and CV risk factors after CT angiography. JACC Cardiovasc Imaging 6:5 (2013), 574–581.
8. [8] Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III) final report. Circulation 106 (2002), 3143–3421.
9. [9] James, P.A., Oparil, S., Carter, B.L., Cushman, W.C., Dennison-Himmelfarb, C., Handler, J., et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA J. Am. Med. Assoc. 311:5 (2014), 507–520.
10. [10] Chamberlain, J.J., Rhinehart, A.S., Shaefer, C.F. Jr., Neuman, A., Diagnosis and management of diabetes: synopsis of the 2016 American diabetes association standards of medical care in diabetes. Ann. Intern. Med. 164:8 (2016 Apr 19), 542–552.
11. [11] Bittencourt, M.S., Hulten, E., Ghoshhajra, B., O'Leary, D., Christman, M.P., Montana, P., et al. Prognostic value of non-obstructive and obstructive coronary artery disease detected by coronary computed tomography angiography to identify cardiovascular events. Circ. Cardiovasc Imaging(7), 2014, 282–291.
12. [12] Abbara, S., Arbab-Zadeh, A., Callister, T.Q., Desai, M.Y., Mamuya, W., Thomson, L., et al. SCCT guidelines for performance of coronary computed tomographic angiography: a report of the Society of Cardiovascular Computed Tomography Guidelines Committee. J. Cardiovasc Comput. Tomogr. 3:3 (2009), 190–204.
13. [13] Agatston, A.S., Janowitz, W.R., Hildner, F.J., Zusmer, N.R., Viamonte, M. Jr., Detrano, R., Quantification of coronary artery calcium using ultrafast computed tomography. J. Am. Coll. Cardiol. 15:4 (1990), 827–832.
14. [14] Halliburton, S.S., Abbara, S., Chen, M.Y., Gentry, R., Mahesh, M., Raff, G.L., et al. SCCT guidelines on radiation dose and dose-optimization strategies in cardiovascular CT. J. Cardiovasc Comput. Tomogr. 5:4 (2011), 198–224.
15. [15] Leipsic, J., Abbara, S., Achenbach, S., Cury, R., Earls, J.P., Mancini, G.J., et al. SCCT guidelines for the interpretation and reporting of coronary CT angiography: a report of the Society of Cardiovascular Computed Tomography Guidelines Committee. J. Cardiovasc Comput. Tomogr. 8:5 (2014), 342–358.
16. [16] Cheezum, M.K., Subramaniyam, P.S., Bittencourt, M.S., Hulten, E.A., Ghoshhajra, B.B., Shah, N.R., et al. Prognostic value of coronary CTA vs. exercise treadmill testing: results from the Partners registry. Eur. Heart J. Cardiovasc Imaging 16:12 (2015), 1338–1346.
17. [17] Min, J.K., Shaw, L.J., Devereux, R.B., Okin, P.M., Weinsaft, J.W., Russo, D.J., et al. Prognostic value of multidetector coronary computed tomographic angiography for prediction of all-cause mortality. J. Am. Coll. Cardiol. 50:12 (2007), 1161–1170.
18. [18] Tobacco Control, Reversal of Risk after Quitting Smoking. IARC Handbooks of Cancer Prevention, vol. 11, 2007, 11.
19. [19] van Domburg, R.T., Meeter, K., van Berkel, D.F., Veldkamp, R.F., van Herwerden, L.A., Bogers, A.J., Smoking cessation reduces mortality after coronary artery bypass surgery: a 20-year follow-up study. J. Am. Coll. Cardiol. 36:3 (2000), 878–883.
20. [20] Le, J., Zhang, D., Menees, S., Chen, J., Raghuveer, G., “Vascular age” is advanced in children with atherosclerosis-promoting risk factors. Circ. Cardiovasc. imaging 3:1 (2010), 8–14.
21. [21] Inoue, T., Cigarette smoking as a risk factor of coronary artery disease and its effects on platelet function. Tob. Induc. Dis. 2:1 (2004), 27–33.
22. [22] Ambrose, J.A., Barua, R.S., The pathophysiology of cigarette smoking and cardiovascular disease: an update. J. Am. Coll. Cardiol. 43:10 (2004), 1731–1737.
23. [23] Shah, R.S., Cole, J.W., Smoking and stroke: the more you smoke the more you stroke. Expert Rev. Cardiovasc Ther. 8:7 (2010), 917–932.
24. [24] McEvoy, J.W., Nasir, K., DeFilippis, A.P., Lima, J.A., Bluemke, D.A., Hundley, W.G., et al. Relationship of cigarette smoking with inflammation and subclinical vascular disease: the Multi-Ethnic Study of Atherosclerosis. Arteriosclerosis, thrombosis, Vasc. Biol. 35:4 (2015), 1002–1010.
25. [25] Samanta, S., Balasubramanian, S., Rajasingh, S., et al. MicroRNA: a new therapeutic strategy for cardiovascular diseases. Trends Cardiovasc Med. 26 (2016), 407–419.
26. [26] Mobarrez, F., Antoniewicz, L., Bosson, J.A., Kuhl, J., Pisetsky, D.S., Lundback, M., The effects of smoking on levels of endothelial progenitor cells and microparticles in the blood of healthy volunteers. PloS one, 9, 2014, e90314.
27. [27] Wronska, A., Kurkowska-Jastrzebska, I., Santulli, G., Application of microRNAs in diagnosis and treatment of cardiovascular disease. Acta Physiol. (Oxf) 213 (2015), 60–83.
28. [28] Novak, J., Olejnickova, V., Tkacova, N., Santulli, G., Mechanistic role of MicroRNAs in coupling lipid metabolism and atherosclerosis. Adv. Exp. Med. Biol. 887 (2015), 79–100.
29. [29] Jefferis, B.J., Lowe, G.D., Welsh, P., Rumley, A., Lawlor, D.A., Ebrahim, S., et al. Secondhand smoke (SHS) exposure is associated with circulating markers of inflammation and endothelial function in adult men and women. Atherosclerosis 208:2 (2010), 550–556.
30. [30] Kallio, K., Jokinen, E., Saarinen, M., Hamalainen, M., Volanen, I., Kaitosaari, T., et al. Arterial intima-media thickness, endothelial function, and apolipoproteins in adolescents frequently exposed to tobacco smoke. Circulation Cardiovasc. Qual. outcomes 3:2 (2010), 196–203.